Will Pfizer’s Full FDA Approval Persuade People To Get Vaccinated? Polling Suggests It Will
The Food and Drug Administration (FDA) granted full approval to Pfizer/BioNTech’s Covid-19 vaccine Monday, potentially helping to combat vaccine hesitancy and encourage more Americans to get the shot as polling has repeatedly shown full approval could influence those who are still unvaccinated.
A poll from the Kaiser Family Foundation (KFF) conducted June 8-21 found 31% of unvaccinated adults would be more likely to get the Covid-19 vaccine if one of the vaccines received full approval.
A YouGov poll conducted July 24-27 found among unvaccinated adults who said they do not plan to get the shot, 9% would get vaccinated if it received full authorization and 38% were unsure, the second highest of any reason for vaccination polled.
A Harris poll conducted June 4-6 asked respondents if full FDA approval would make them more likely to get vaccinated, knowing that full FDA approval means that vaccine manufacturers could then market their product directly to consumers.
Nearly half—47%—of unvaccinated respondents said the approval would make them more likely to get vaccinated, and 54% of the unvaccinated said hearing directly from the pharmaceutical companies behind the vaccine would make them more comfortable about getting vaccinated in general.
A poll conducted by the de Beaumont Foundation and Republican-aligned pollster Frank Luntz August 4-5 found 56% of unvaccinated parents said full FDA approval would make them feel more confident in the vaccine’s safety.
While the Pfizer vaccine was only fully approved for those 16 years and older and is still under an emergency use authorization for ages 12 to 15, 51% of unvaccinated parents said full FDA approval would make them more likely to get their children vaccinated against Covid-19.
73%. That’s the percentage of U.S. adults who have received at least one Covid-19 vaccine dose as of Monday, according to the Centers for Disease Control and Prevention (CDC), leaving more than a quarter of adults still unvaccinated. Among 16-17 year olds who are also now covered by the full FDA approval, only 55.9% have received at least one dose.
The Harris poll also found that many unvaccinated adults may have actually rooted against full FDA approval, which now clears the way for more places to enact stricter vaccine requirements. The poll found 51% of unvaccinated respondents strongly or somewhat opposed vaccine manufacturers getting full approval after being told it “provides schools and employers a pathway to mandate vaccines.”
FDA regulators said Monday they granted full authorization to Pfizer’s vaccine after an “incredibly thorough and thoughtful evaluation,” with Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, noting the vaccine remains largely protective against Covid-19 infections and “is clearly effective in preventing hospitalization and death.” The vaccine is still under an emergency use authorization for 12- to 15-year-olds and the immunocompromised, and Moderna and Johnson & Johnson’s Covid-19 vaccines are still not fully approved. The authorization comes as widespread vaccine hesitancy has remained an issue throughout the pandemic, though vaccinations have picked up slightly amid the nationwide Covid-19 surge linked to the highly transmissible delta variant. In addition to the vaccines lacking full FDA approval, those who still haven’t been vaccinated have cited such reasons for not getting the shot as how quickly the vaccine was developed, concerns about side effects, distrust in the government or vaccines in general and not believing Covid-19 is enough of a risk to justify vaccination.
FDA Approves Pfizer Coronavirus Vaccine (Forbes)
Here Are The Groups That Still Won’t Get The Covid Vaccine—And Why (Forbes)
How Full FDA Approval Could Spur Vaccination (Kaiser Family Foundation)
One in 12 unvaccinated Americans say $100 would change their mind about the COVID-19 vaccine (YouGov)
Poll: Confidence in Vaccine Safety Growing; Delta Variant and Pending FDA Approval Could Boost Numbers (de Beaumont Foundation)